The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 493-505

  Vigil, Patrick D ^a   Wiles, Travis J ^b   Engstrom, Michael D ^a   Prasov, Lev ^a   Mulvey, Matthew A ^b   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN; TOS A PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; CELL DAMAGE; CELL FRACTIONATION; CELL SURFACE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE LOCUS; GENETIC CODE; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; IMMUNOGOLD ELECTRON MICROSCOPY; IN VIVO STUDY; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; URINARY TRACT; UROPATHOGENIC ESCHERICHIA COLI; UROSEPSIS; VACCINATION; ZEBRA FISH;

ANIMALS; BACTEREMIA; BACTERIAL ADHESION; BACTERIAL TOXINS; BACTERIAL VACCINES; CELL LINE; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICE; PROTEIN TRANSPORT; PYELONEPHRITIS; SEPSIS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; UROTHELIUM; VIRULENCE; ZEBRAFISH;

EID: 84857147041     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05713-11     Document Type: Article

References (42)

1. Al-Hasan MN, Eckel-Passow JE, Baddour LM. 2010. Bacteremia complicating gram-negative urinary tract infections: a population-based study. J. Infect. 60:278 -285.
2. Baga M, Goransson M, Normark S, Uhlin BE. 1985. Transcriptional activation of a pap pilus virulence operon from uropathogenic Escherichia coli. EMBO J. 4:3887-3893.
3. Brahamsha B. 1996. An abundant cell-surface polypeptide is required for swimming by the nonflagellated marine cyanobacterium Synechococcus. Proc. Natl. Acad. Sci. U. S. A. 93:6504-6509.
4. Brooks HJ, O'Grady F, McSherry MA, Cattell WR. 1980. Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection. J. Med. Microbiol. 13:57-68.
5. Brzuszkiewicz E, et al. 2006. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl. Acad. Sci. U. S. A. 103:12879 -12884.
6. Chin BS, et al. 2011. Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection (UTI) patients. Arch. Gerontol. Geriatr. 52:e50-e55.
7. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
8. Dobrindt U, Emody L, Gentschev I, Goebel W, Hacker J. 2002. Efficient expression of the alpha-haemolysin determinant in the uropathogenic Escherichia coli strain 536 requires the leuX-encoded tRNA(5)(Leu). Mol. Genet. Genomics 267:370 -379.
9. Duong F, Soscia C, Lazdunski A, Murgier M. 1994. The Pseudomonas fluorescens lipase has a C-terminal secretion signal and is secreted by a three-component bacterial ABC-exporter system. Mol. Microbiol. 11: 1117-1126.
10. Gaynes R, Edwards JR. 2005. Overview of nosocomial infections caused by gram-negative bacilli. Clin. Infect. Dis. 41:848-854.
11. Gransden WR, Eykyn SJ, Phillips I, Rowe B. 1990. Bacteremia due to Escherichia coli: a study of 861 episodes. Rev. Infect. Dis. 12:1008 -1018.
12. Hacker J, Hughes C, Hof H, Goebel W. 1983. Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice. Infect. Immun. 42:57-63.
13. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL. 2010. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog. 6:e1001187.
14. Hagberg L, et al. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
15. Haugen BJ, et al. 2007. In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA. Infect. Immun. 75:278-289.
16. Holden NJ, Uhlin BE, Gally DL. 2001. PapB paralogues and their effect on the phase variation of type 1 fimbriae in Escherichia coli. Mol. Microbiol. 42:319 -330.
17. Hultdin UW, et al. 2010. Structure of FocB: a member of a family of transcription factors regulating fimbrial adhesin expression in uropathogenic Escherichia coli. FEBS J. 277:3368 -3381.
18. Ikaheimo R, Siitonen A, Karkkainen U, Kuosmanen P, Makela PH. 1993. Characteristics of Escherichia coli in acute community-acquired cystitis of adult women. Scand. J. Infect. Dis. 25:705-712.
19. Juarez A, et al. 2000. Interaction of the nucleoid-associated proteins Hha and H-NS to modulate expression of the hemolysin operon in Escherichia coli. Adv. Exp. Med. Biol. 485:127-131.
20. Lindberg S, et al. 2008. Regulatory Interactions among adhesin gene systems of uropathogenic Escherichia coli. Infect. Immun. 76:771-780.
21. Linhartova I, et al. 2010. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol. Rev. 34:1076 -1112.
22. Lloyd AL, Henderson TA, Vigil PD, Mobley HL. 2009. Genomic islands of uropathogenic Escherichia coli contribute to virulence. J. Bacteriol. 191: 3469-3481.
23. Lloyd AL, Rasko DA, Mobley HL. 2007. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J. Bacteriol. 189:3532-3546.
24. Loomes LM, Kerr MA, Senior BW. 1993. The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. J. Med. Microbiol. 39:225-232.
25. Mobley H, et al. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
26. Okuda K, et al. 1997. Role for the S-layer of Campylobacter rectus ATCC 33238 in complement mediated killing and phagocytic killing by leukocytes from guinea pig and human peripheral blood. Oral Dis. 3:113-120.
27. Parham NJ, et al. 2005. Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coli. J. Clin. Microbiol. 43:2425-2434.
28. Satchell K. 2007. MARTX, multifunctional autoprocessing repeats-intoxin toxins. Infect. Immun. 75:5079 -5084.
29. Shibuya Y, et al. 1991. Pseudomonas aeruginosa alkaline proteinase might share a biological function with plasmin. Biochim. Biophys. Acta 1077: 316-324.
30. Sleytr UB, Beveridge TJ. 1999. Bacterial S-layers. Trends Microbiol. 7:253-260.
31. Smith SN, Hagan EC, Lane MC, Mobley HLT. 2010. Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. mBio 1(5):e00262-10. doi:10.1128/mBio.00262-10.
32. Smith YC, Rasmussen SB, Grande KK, Conran RM, O'Brien AD. 2008. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 h after intraurethral inoculation of mice. Infect. Immun. 76:2978 -2990.
33. Taichman NS, et al. 1987. Comparative studies on the biology of Actinobacillus actinomycetemcomitans leukotoxin in primates. Oral Microbiol. Immunol. 2:97-104.
34. Vigil PD, Alteri CJ, Mobley HL. 2011. Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence. Infect. Immun. 79:2335-2344.
35. Vigil PD, et al. 2011. Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. mBio 2(3):00066-11. doi: 10.1128/mBio.00066-11.
36. Warren J, et al. 1983. A randomized, controlled trial of cefoperazone versus cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Rev. Infect. Dis. 5(Suppl. 1): S173-S180.
37. Welch RA. 1991. Pore-forming cytolysins of gram-negative bacteria. Mol. Microbiol. 5:521-528.
38. Welch RA, et al. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:17020 -17024.
39. Wiles TJ, Bower JM, Redd MJ, Mulvey MA. 2009. Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog. 5:e1000697.
40. Woods RG, Burger M, Beven CA, Beacham IR. 2001. The aprX-lipA operon of Pseudomonas fluorescens B52: a molecular analysis of metalloprotease and lipase production. Microbiology 147:345-354.
41. Xia Y, Forsman K, Jass J, Uhlin BE. 1998. Oligomeric interaction of the PapB transcriptional regulator with the upstream activating region of pili adhesin gene promoters in Escherichia coli. Mol. Microbiol. 30:513-523.
42. Xia Y, Gally D, Forsman-Semb K, Uhlin BE. 2000. Regulatory cross-talk between adhesin operons in Escherichia coli: inhibition of type 1 fimbriae expression by the PapB protein. EMBO J. 19:1450 -1457.